Dany Barrak - Concepedia

Author

Dany Barrak

Fox Chase Cancer Center ORCID

Also Known As

D. Barrak, Dany Barrak, Dany K. Barrak, Victoria A. Forte

Publications

211

Citations

H-Index

Concepts

All Affiliations

Fox Chase Cancer Center Georgetown University Saint John's Health Center

About

Dany Barrak is an author at Fox Chase Cancer Center specializing in pathology, oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	69
2	Engineering	1	1	17
3	Biomedical Engineering	1	1	17
4	Cell Biology	1	1	17
5	Immunology	1	1	17

Dany Barrak

Publications

151

Citations

H-Index

Page 1

	Year	Citations
EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low Alexander Ring, Neal Mineyev, Weizhu Zhu, Oncotarget	2015	33
Regionalization of Retroperitoneal Sarcoma Surgery to High-Volume Hospitals: Missed Opportunities for Outcome Improvement Anthony M. Villano, Alexander Zeymo, James McDermott, Journal of Oncology Practice	2018	19
Total neoadjuvant therapy for pancreatic adenocarcinoma increases probability for a complete pathologic response Dany Barrak, Anthony M. Villano, Nicole Villafañe-Ferriol, European Journal of Surgical Oncology Surgical OncologyPancreatic CancerTotal Neoadjuvant TherapyGastrointestinal OncologyMedicine	2022	19
Disparities in Risk Reduction Therapy Recommendations for Young Women With Lobular Carcinoma In-Situ Bradley C. Bandera, Amy Voci, Daniel W. Nelson, Clinical Breast Cancer	2020	18
The potential for liquid biopsies in the precision medical treatment of breast cancer. Victoria Forte, Dany Barrak, Mostafa Elhodaky, eScholarship (California Digital Library) Breast OncologyEngineeringBreast Cancer ReliesPathologyBiomedical Engineering	2016	17
The Immune Microenvironment Impacts Survival in Western Patients with Gastric Adenocarcinoma Abhineet Uppal, Ahmed Dehal, Shu‐Ching Chang, Journal of Gastrointestinal Surgery Immune EvasionCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2019	17
Total Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinoma Is Associated With Limited Lymph Node Yield but Improved Ratio Dany Barrak, Anthony M. Villano, Maitham A. Moslim, Journal of Surgical Research Surgical OncologyPancreatic CancerGastrointestinal OncologyMedicinePathology	2022	16
Total neoadjuvant therapy is associated with improved overall survival and pathologic response in pancreatic adenocarcinoma Anthony M. Villano, Eileen A. O’Halloran, Neha Goel, Journal of Surgical Oncology	2022	12

Page 1